Publicacions en què col·labora amb Remedios Otero Candelera (18)

2017

  1. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

    Chest, Vol. 151, Núm. 3, pp. 564-571

  2. FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence

    Clinical and Translational Oncology, Vol. 19, Núm. 8, pp. 997-1009

  3. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

    American Journal of Medicine, Vol. 130, Núm. 3, pp. 337-347

2015

  1. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs

    American Journal of Medicine, Vol. 128, Núm. 1, pp. 90.e9-90.e15

  2. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity

    Journal of Thrombosis and Haemostasis, Vol. 13, Núm. 7, pp. 1274-1278

  3. Fondaparinux in the initial and long-term treatment of venous thromboembolism

    Thrombosis Research, Vol. 135, Núm. 2, pp. 311-317

2013

  1. Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: Data from the RIETE registry

    Respiratory Research, Vol. 14, Núm. 1

2012

  1. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism

    Journal of Thrombosis and Haemostasis, Vol. 10, Núm. 5, pp. 751-759

2011

  1. Prevention of venous thromboembolism in patients with cancer in Spain

    Journal of Coagulation Disorders, Vol. 3, Núm. 1, pp. 64-68

2008

  1. Clinical predictors for fatal pulmonary embolism in 15 520 patients with venous thromboembolism: Findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) registry

    Circulation, Vol. 117, Núm. 13, pp. 1711-1716

  2. Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry

    Thrombosis and Haemostasis, Vol. 99, Núm. 3, pp. 546-551

  3. Gammagrafía pulmonar y tomografía computarizada helicoidal en el diagnóstico de embolia pulmonar en España. Datos del Sistema Nacional de Salud y el Registro RIETE

    Medicina Clinica, Vol. 130, Núm. 15, pp. 568-572

2007

  1. Haemodynamically unstable pulmonary embolism in the RIETE Registry: Systolic blood pressure or shock index?

    European Respiratory Journal, Vol. 30, Núm. 6, pp. 1111-1116

  2. Venous thromboembolism during pregnancy or postpartum: Findings form the RIETE Registry

    Thrombosis and Haemostasis, Vol. 97, Núm. 2, pp. 186-190

2006

  1. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: Findings from the RIETE registry

    Journal of Thrombosis and Haemostasis, Vol. 4, Núm. 9, pp. 1950-1956

  2. Fixed-dose low-molecular-weight heparin, bemiparin, in the long-term treatment of venous thromboembolism in patients with transient risk factors in standard clinical practice: The FLEBUS study [7]

    Journal of Thrombosis and Haemostasis

2004

  1. The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry

    Journal of Thrombosis and Haemostasis, Vol. 2, Núm. 11, pp. 1892-1898

2003

  1. Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized, double-blind clinical trial

    Journal of Thrombosis and Haemostasis, Vol. 1, Núm. 3, pp. 425-432